February 1, 2013 – Early detection of cancer offers patients more therapy options and better outcomes. Cancer screening is an important diagnostic tool to detect tumors at their earliest stages; however, not all types of cancer, including mesothelioma, have effective screening tests. For that reason, researchers continue to work toward development of new and more effective methods to detect cancer even before any symptoms appear. Researchers at the Massachusetts Institute of Technology (MIT) have developed a new technique that may improve early-stage cancer detection.
Nanoparticles Developed to Enhance the Presence of Biomarkers
Recent developments in cancer research have shown that cancer cells produce and secrete a variety of specific proteins, or “biomarkers”, that are not found in healthy cells. Researchers are optimistic that these biomarkers can help detect the presence of cancer, as well as possibly the specific type of cancer. The number of these biomarkers is often quite low, however, making them difficult to detect. As a result, until a detectible number of biomarkers become obvious, the cancer has more time to grow and advance.
The researchers at MIT have developed a new technology using nanoparticles that can enhance or increase the biomarker production. These nanoparticles have the ability to locate a tumor and interact with the proteins found on cancer cells. This interaction produces thousands of biomarkers that can be easily identified in a urine sample. Not only will this improve chances of early detection, this new technology can also help physicians identify specific cancers, monitor disease progression and track how tumors react to certain therapies such as chemotherapy and radiation.
Philadelphia Mesothelioma Lawyers at Shein Law: Committed to Helping Mesothelioma Victims and Their Families
The New Jersey and Pennsylvania mesothelioma lawyers at Shein Law are encouraged by any research that gives hope of increased survival rates and improved quality of life for mesothelioma patients, as we have witnessed firsthand the devastating effects of the disease. For more than 25 years, Benjamin Shein and his team of compassionate and dedicated lawyers have fought for the rights of individuals suffering from asbestos-related diseases as well as have financially supported research efforts. We are optimistic that this new amplified biomarker technology will have a positive impact within the mesothelioma community and eventually lead to the ultimate goal of saving lives.
If you or someone you love has been exposed to asbestos and has developed mesothelioma, lung cancer or any other asbestos-related illness, contact us today. We have offices in Philadelphia, Pennsylvania and Pennsauken, New Jersey, but our attorneys will be glad to meet with you at location convenient to you and your family. Call 1-877-SHEINLAW (743-4652) to schedule an appointment for a free and confidential consultation or fill out our online contact form.